Serial CTRS was developed from routine-care CTs and externally validated across 10 institutions and the phase 1 GARNET trial, covering ICI monotherapy and combinations across all lines. Multivariable ...
A deep-learning serial CT biomarker improves survival prediction in immunotherapy-treated NSCLC and outperforms RECIST. Find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results